Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | In Stock | |
5 mg | $647 | In Stock | |
10 mg | $987 | In Stock |
Description | Bedinvetmab (ZTS-00508841) is a canine monoclonal antibody (mAb) engineered to target nerve growth factor (NGF). Bedinvetmab prevents NGF from binding its receptors, tropomyosin receptor kinase A (trkA) and p75 neurotrophin receptor (p75NTR). Bedinvetmab is primarily utilized in osteoarthritis research, where it is studied for its ability to manage pain in canine models. |
In vivo | Bedinvetmab (0.5-1 mg/kg, subcutaneous injection, every 28 days) can effectively alleviate pain associated with canine osteoarthritis [1]. Bedinvetmab (1 mg/kg, subcutaneous injection, monthly; 3-fold and 10-fold doses) demonstrated good tolerability when co-administered with Carprofen in normal laboratory beagle dogs [2]. |
Synonyms | ZTS-00508841, ZTS00508841 |
Cas No. | 2171034-69-6 |
Color | Transparent |
Appearance | Liquid |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.